跳至主要内容
临床试验/NCT02510040
NCT02510040已完成不适用

A Prospective Observational Study of Adult Strabismus

Jaeb Center for Health Research1 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2015年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
217
试验地点
1
主要终点
Number of Participants With Symptom Success at 10 Weeks

研究概览

简要总结

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia.

详细描述

The purpose of this study is to describe clinical characteristics, treatments, and one-year outcomes of adults with convergence insufficiency, divergence insufficiency, or small angle hypertropia. Treatment comparisons within the studied conditions will also be done to help develop future studies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Number of Participants With Symptom Success at 10 Weeks

时间窗: 10 weeks after enrollment

In the convergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as improvement of CI Symptom Survey (CISS) score of at least 9 points and an outcome score of \<21 points. In the divergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as diplopia "rarely" or "never" in primary position at distance on the diplopia questionnaire. In the small-angle hypertropia group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as diplopia "rarely" or "never" both in primary position at distance and in reading position on the diplopia questionnaire.

Number of Participants With Symptom Success at 12 Months

时间窗: 12 months after enrollment

In the convergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as improvement of CI Symptom Survey (CISS) score of at least 9 points and an outcome score of \<21 points. In the divergence insufficiency group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as diplopia "rarely" or "never" in primary position at distance on the diplopia questionnaire. In the small-angle hypertropia group, the primary outcome will be symptom success at the 10-week and 12-month visit, defined as diplopia "rarely" or "never" both in primary position at distance and in reading position on the diplopia questionnaire.

次要结局

  • Mean of Near Point of Convergence in Convergence Insufficiency Group(12 months after enrollment)
  • Mean Positive Fusional Vergence in Convergence Insufficiency Group(12 months after enrollment)
  • Adult Strabismus 20 Questionnaire Score (CI)(12 months after enrollment)
  • Adult Strabismus 20 Questionnaire Score (DI)(12 months after enrollment)
  • Mean Convergence Insufficiency Symptom Survey Score(12 months after enrollment)

研究者

发起方
Jaeb Center for Health Research
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验